Factor time for active immunotherapy after cytoreductive chemotherapy-Reference-Cited by-同舟云学术

Factor time for active immunotherapy after cytoreductive chemotherapy

Published:1974-02 Issue:2 Volume:10 Page:89-91
ISSN:0014-2964
Container-title:European Journal of Cancer (1965)
language:en
Short-container-title:European Journal of Cancer (1965)

Author:

Amiel J.L.,Berardet Micheline

Publisher

Elsevier BV

Subject

General Medicine

Reference13 articles.

1. Immunothérapie active non spécifique par le BCG de la leucémie virale E♂ G2 chez des receveurs isogéniques;Amiel;Rev. franç. Etud. clin. biol.,1967

2. Immunothérapie active de la leucémie L1210 appliquée apres la greffe tumorale;Mathe;Rev. franç. Etud. clin. biol.,1968

3. Essais de traitement de la leucémie Eo G2 associant chimiothérapie et immunothérapies actives non spécifique et spécifique;Amiel;Rev. franç. Etud. clin. biol.,1969

4. Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by vincristine or adamantadine;Mathe;Europ. J. clin. biol. Res.,1971

5. Etude de l'effet immunodépresseur des composés chimiques utilisés en chimiothérapie anticancéreuse;Amiel;Europ. J. Cancer,1967

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized Trial of Chemoimmunotherapy in Advanced Non-Oat-Cell Lung Cancer;Tumori Journal;1982-12

2. Collaboration between specific anti-tumor immunity and chemotherapeutic agents;International Journal of Cancer;1980-03-15

3. Trends in immunopotentiation;International Journal of Immunopharmacology;1980-01

4. Literaturverzeichnis;Harnblasentumoren;1979

5. First Results of a Randomized Trial on Immunotherapy of Head and Neck Tumors;Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II;1979